Home pagePress monitoringNew findings on the genomic guardian - p53 protein

New findings on the genomic guardian - p53 protein

Date: 22.3.2007 

The p53 protein routinely shuts down damaged cells and is one of our main lines of defence against cancer. Scientists at Karolinska Institutet in Sweden now present new findings on how p53 carries out this all-important function. The p53 transcription factor is found in every cell of the body, where it helps to prevent cancer by activating and deactivating the right genes. When the cell is exposed to potentially carcinogenic stress, such as DNA damage or oxygen deficiency, p53 can, for example, switch on the genetic programme for cell death, preventing the cancer from spreading to the rest of the body. Almost half of all cancer tumours involve a mutation of the gene for p53, and in the hope of developing new cancer therapies, many cancer researchers study the mechanisms the protein controls..... read more "www.alphagalileo.org":[ http://www.alphagalileo.org/index.cfm?fuseaction=readrelease&releaseid=519126&ez_search=1]

Cheap molecule may attack tumors - A cheaply-produced molecule may be the key to treating a variety of cancers, claim Canadian researchers Dicholoroacetate (DCA) has been suggested for years as a possible treatment for certain rare metabolic disorders in children The University of Alberta team, writing in the journal Cancer Cell, now say it could encourage cancer cells to die Experts say much more research will be needed before an effective cancer treatment can emerge Whole article onnews (23.4.2007)

Genes Associated With Adverse Reactions To Cancer Radiotherapy Treatment Identified - Medical scientists at the University of Leicester have announced a potentially unique advance in breast cancer research by identifying two genes associated with adverse reaction to cancer treatment The research could mean people who might react badly to radiotherapy could be warned in advance or alternative treatments be sought The team who carried out the study included Drs Paul Symonds, Mark Plumb, Irene Peat and George Giotopoulos of the Department of Cancer Studies and Molecular Medicine and the Department of Genetics at the University of Leicester Whole article on ScienceDaily (21.4.2007)

New Cell Type Identified In Cancer Development - Scientists have discovered a new type of cell that appears to play a role in the development of cancer -- a highly volatile, precancerous stem cell that can either remain benign or become malignant, depending upon environmental cues Current cancer stem cell theory holds that tumors are comprised of a variety of cell types Cancer stem cells were first identified in leukemia, but they have also been found in breast, brain, colon and prostate cancers But a team of scientists, led by Dr Whole article: www (21.3.2007)

Scientists look at precancerous cells - Researchers in Boston have identified how a missing protein causes tissue to become precancerous, the Massachusetts Institute of Technology announced The finding could help identify patients at risk of developing tumors, MIT said Most breast and prostate tumors are missing the protein but it has not been clear what role the protein, known as 14-3-3 sigma, played in tumor growth "The cells try to divide and try to divide, and they just give up Whole article: www (19.3.2007)

MicroRNA Helps Prevent Tumors - MicroRNAs are tiny snippets of RNA that can repress activity of a gene by targeting the gene's messenger RNA (which copies DNA information and starts the process of protein production) The first microRNA was discovered in 1993, in worms But given the wealth of microRNAs, and the ability of individual microRNAs to target hundreds of genes, researchers have struggled to show the biological impact of a particular microRNA on a particular target in mammals (although such connections have been shown in plants, worms and flies) Looking to find a promising target for an individual microRNA, Christine Mayr, a postdoctoral researcher in the Bartel lab, picked Hmga2, a gene that is defective in a wide range of tumors In these tumors, the protein-producing part of the Hmga2 gene is cut short and replaced with DNA from another chromosome Whole article: www (28.2.2007)

 

OPPI, MPO, EU

CEBIO

  • CEBIO
  • BC AV CR
  • Budvar
  • CAVD
  • CZBA
  • Eco Tend
  • Envisan Gem
  • Gentrend
  • JAIP
  • Jihočeská univerzita
  • Madeta
  • Forestina
  • ALIDEA

LinkedIn
TOPlist